Extracellular volume fraction measured by computed tomography predicts improvement in cardiac function after catheter ablation for atrial fibrillation
Abstract
Heart failure (HF) is one of the important events in patients with atrial fibrillation (AF). However, the prognostic and diagnostic significance of computed tomography (CT)-derived left ventricular extracellular volume fraction (ECV), which reflects diffuse left ventricular fibrosis, remains unclear. To evaluate whether ECV is associated with surrogate markers of HF (B-type natriuretic peptide (BNP), left atrial volume index, and tissue Doppler-derived E/e’ ratio) and whether it predicts post-ablation improvement in left ventricular ejection fraction (LVEF) in patients with AF. We conducted a cohort study, including 423 consecutive patients (median age: 73 years; 70% male; 53% with paroxysmal AF; mean LVEF: 59 ± 11%) scheduled for catheter ablation. Left ventricular ECV was measured using routine contrast-enhanced CT. The mean ECV was 29.1 ± 5.9%, and baseline BNP levels were 90.7 [40.1–174.4] pg/mL. High ECV, defined as > 35%, was observed in 15% of patients. ECV was significantly associated with log-transformed BNP, left atrial volume index, and E/e’ ratio (r = 0.463, p < 0.001; r = 0.324, p < 0.001; and r = 0.255, p < 0.001, respectively; Figure). Multivariable logistic regression analysis revealed that ECV was independently associated with BNP > 100 pg/mL after adjustment for age, sex, AF phenotype, and LVEF (odds ratio = 1.14, 95% CI: 1.09–1.20 per 1% increase in ECV, p < 0.001). Furthermore, in a subgroup of 32 patients with non-ischemic dilated cardiomyopathy (LVEF < 50%), LVEF improved from 37.4 ± 7.6% to 55.8 ± 11.9% at 6 months after ablation (ΔLVEF: 18.4 ± 11.7%). A significant inverse correlation was observed between ECV and ΔLVEF (r = -0.561, p < 0.001; Figure). CT-derived left ventricular ECV was feasible to measure, correlated with established markers of heart failure, and predicted improvement in LVEF after catheter ablation.Figure